Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: J Mol Cell Cardiol. 2015 May 22;85:104–116. doi: 10.1016/j.yjmcc.2015.05.012

Figure 1. Impact of MnTBAP on body composition and glucose tolerance in UCP-DTA and db/db mice.

Figure 1

A, B. Relative distribution of fat and lean mass as measured by DEXA in 13 and 24 week-old UCP-DTA mice vs. controls, respectively. Lean and fat mass is expressed as % of total body mass (n=3–9). C–E. Glucose tolerance tests in 13 week-old UCP-DTA, 24 week-old UCP-DTA, and 9 week-old db/db mice, respectively (n=6–15). Mice were treated with MnTBAP or saline, as indicated. Maximum glucose concentration detectable by the glucometer is 600mg/dl. *p<0.05 vs. other genotypes; $ p<0.05 vs. WT saline and WT MnTBAP.